Back to Stakeholders

Rose Hill Life Sciences is a North American psychedelic life sciences company that supplies research-grade Psilocybe cubensis biomass and sponsors clinical trials, including the PHATHOM study testing psilocybin combined with physical therapy to restore motor function in stroke patients; it also collaborates with Johns Hopkins, the University of Guelph, and the Canadian Centre for Psychedelic Science, and has operated a psilocybin mushroom cultivation facility since 2015.

Quick Facts

Type
Private Biotech
HQ
Canada
Website
Visit

Collaborated Trials

1